evipedia.ai
← Back

Semax for Health & Longevity

Created on 10/27/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Semax, a short synthetic peptide administered as nasal drops, is a medicine registered in Russia for stroke, memory problems tied to poor brain circulation, and optic nerve disease. Small Russian studies, mostly from its developers and their clinical partners, point toward faster stroke recovery; claims of sharper memory and focus in healthy adults rest on limited reports. Reported side effects are few, but most product outside Russia is unregulated. (Full Review)

Protocol

Standard nasal course (0.1% drops)
500–5000 µg daily
200–2000 µg per dose (2–3 drops per nostril, 50 µg per drop); 3–5 days, extendable to 14 days
Time of day
Morning and midday
As in the label’s pediatric schedule; evening doses are commonly avoided because of stimulating effects
Single versus split dosing
Larger daily amounts split
Into repeated doses 10–15 minutes apart or several daily doses
Time to effect
Functional recovery after ischemic stroke
After 10-day courses
When clinical benefits were assessed; rehabilitation used two courses 20 days apart
Healing of treatment-resistant peptic ulcers
By day 14
After a 10-day course of 1% drops added to standard regimens
Pharmacology
Within about 4 minutes
Brain entry per the label; effects lasting 20–24 hours

Benefits

Contraindications
  • Pregnancy and breastfeeding
  • History of seizures
  • Acute psychosis or anxiety disorders
  • Known hypersensitivity to Semax or methylparaben
  • Children under 5 years (0.1% drops)
  • Bipolar disorder with recent mania (inferred; no human data)
    •
Key Interactions
  • Nasal decongestants (oxymetazoline, xylometazoline)
    •
Theoretical (inferred from mechanism)
  • Stimulants (amphetamine, modafinil) and caffeine
  • Serotonergic drugs and supplements (SSRIs, St John’s wort)
  • Antipsychotics (haloperidol, risperidone)
  • Opioids (morphine, oxycodone)
  • Anticoagulants and antiplatelets (warfarin, aspirin) and clotting-affecting supplements (fish oil, Ginkgo biloba)
  • Other nootropic agents (Selank, Cerebrolysin)
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Nasal mucosal irritation; seizure-like brain activity
    •
  • Speculative: Overstimulation, anxiety, or psychosis; immune reactions and contamination from unregulated products
    •

Monitoring

Marker Target Why
Plasma BDNF No established target; track change from own baseline Expected to change: rose with Semax in stroke rehabilitation
Cognitive test battery score No established target; track change from own baseline Expected to change: the claimed cognitive benefit
EEG No established target; track absence of new seizure-type activity versus baseline Safety check: seizure-type activity stops use

Cadence: Baseline before starting; cognitive test repeated at the end of each 10–14 day course and 2–4 weeks after stopping; side effects reviewed daily during the first course; EEG repeated only if new neurological symptoms appear

Qualitative Assessment

  • Mental clarity and sustained focus during demanding work
  • Mental fatigue late in the day
  • Sleep onset time and sleep quality
  • Anxiety, irritability or restlessness
  • Nasal burning, crusting or bleeding
  • Headache
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.